Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Application to Enforce the Final Award by Consent Granted

On 5 January 2021, the Kyiv Court of Appeal granted the application filed by Misen Enterprises AB and LLC Karpatygaz to recognize and permit the enforcement of the Final Award by Consent in case No V 2016/114. The Court ruled to issue a writ of execution to enforce the Final Award by Consent and ordered JSC Ukrgazvydobuvannia to transfer 1,337,978,132.11 UAH (47,060,537.16 US dollars, according to the official rate of exchange of US Dollar to Ukrainian Hryvnia set by the National Bank of Ukraine as of 5 January 2021) to Misen Enterprises AB and 1,001,242.74 UAH to LLC Karpatygaz. The

Norway Royal Salmon (NRS): Q4-20 Trading update

Harvested volumes for the fourth quarter 2020: 7.1 thousand tonnes gutted weight The full Q4 2020 report will be released on 16 February 2021 at 06:30 CET. For further information, please contact:   · CFO Ola Loe, 911 79 411 Norway Royal Salmon in brief The Norway Royal Salmon (NRS) group owns 36 085 tonnes MAB located in Troms and Finnmark. In addition, the group has minority interest in three associated Norwegian fish farming companies which together own 11 fish farming licenses, as well as Arctic Fish on Iceland that has licenses for 11 800 tonnes in MAB. NRS is an

Risk Intelligence A/S reports 31% growth in revenue in Q4 2020

Risk Intelligence A/S (“Risk Intelligence” or "the Company") reports 31% growth in revenue in Q4 2020 compared to Q4 2019 and 8% growth for 2020 compared to 2019.Risk Intelligence has increased revenue by 31% in Q4 2020 (DKK 6,290,592) compared to Q4 2019 (DKK 4,795,609) and increased revenue for the year by 8% (DKK 15,330,873) compared to 2019 (DKK 14,220,894). The 31% growth in Q4 was generated from a combination of growing existing business, with clients increasing the size of their subscription licenses for the Risk Intelligence System and adding other products to their contracts, as

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 5 - 7 JANUARY 2021 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90/2020. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

AFRY acquires ITE Østerhus in Kristiansand, Norway

With the acquisition of ITE Østerhus AS, AFRY establishes itself in an important industrial area in Norway and strengthens its position within process industry.ITE Østerhus specialises in electrical engineering, automation and digitalisation for industrial customers. The company's largest market areas are smelting plants and process- and food industries. ITE Østerhus focus on a wide range of projects of various sizes and complexities. The company delivers integrated solutions including the entire hierarchy of hardware equipment, panel production, automation, system integrations and

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2020

Strong sales growth during 2020; Zinzino group revenue increased with a total of 44% in Q4 and 48% for the full year 2020, compared with the previous year.The revenue in December for Zinzino's sales markets increased by 77% to SEK 127.9 (72.3) million due to strong growth in many regions and countries. Faun Pharma's external sales increased by 158% and amounted to SEK 6.2 (2.4) million. Overall, the Group increased revenues by 80% to SEK 134.1 (74.7) million compared with the previous year. The fourth quarter of 2020 became the strongest quarter in the history of the company. The Zinzino

OmniCar sees major growth in 2021 – Target yearly revenue of SEK 25 million by end of 2021 on a rolling basis.

Update from Omnicar Holding ABSince we launched OmniCarService back in October 2020 we have seen tremendous feedback from our customers after being active for only three months. At this time, we have two fully equipped vans that cover the whole of Copenhagen. Our Key Performance Indicators (KPI) for the first three months counting from October 2020: · Growth in number of customers by 45% – average on a monthly basis. · Growth in revenue by 50% – average on a monthly basis. · Growth in basket size by 20% – average on a monthly basis. Some current key figures and facts for

Q-Free: Conversion of convertible bonds

Reference is made to the stock exchange notices published 5 and 6 January 2021 regarding conversion of Q-Free ASA's NOK 80 million unsecured subordinated convertible bond loan (the "Convertible Bond Loan"), for an aggregate principal amount of NOK 52,000,000. Q-Free ASA has now received additional conversion notices from the paying and conversion agent for the Convertible Bond Loan for bonds representing an additional amount of NOK 15,000,000. The aggregated received conversion notices representing NOK 67,000,000 of the Convertible Bond Loan will be converted into 18,442,566 new shares

Atlas Copco completes acquisition of European distributor of vacuum equipment and service solutions

Nacka, Sweden, January 7, 2021: Atlas Copco has completed the acquisition of Ehrler & Beck GmbH that was announced November 4[th], 2020. The company is a distributor of vacuum equipment and vacuum services.Ehrler & Beck is based in Renningen, Germany and has 15 employees. The company’s sales and service network is active in Germany and neighboring countries. The purchase price is not material relative to Atlas Copco’s market capitalization and is not disclosed. The acquired business will operationally become part of the Industrial Vacuum Division within the Vacuum Technique Business

Musti Group launches a digital veterinary service

Musti Group plc                        Press Release                                  7 January 2021 at 9.30 a.m. Musti Group launches a digital veterinary service Musti Group launches a new digital veterinary service available for all pet owners. Through the service, pet owners can easily contact a veterinarian directly from their home. The service will be launched in Finland at the beginning of February, and it is planned to expand to Sweden and Norway later. “Our mission is to make the lives of pets and their owners easier, safer and more fun. The digital veterinary service

Odfjell SE: Contemplated sustainability-linked bond issue

Odfjell SE (the “Company”) has mandated DNB Markets, Nordea and SEB to arrange a series of fixed income investor calls commencing January 11, 2021.Following the investor calls, a sustainability-linked NOK denominated four-year senior unsecured bond issue may follow, subject to market conditions. Proceeds from the potential bond issue will be used for general corporate purposes, including refinancing of existing bonds. The potential bond issue will be linked to Odfjell’s fleet transition plan and ambition to reduce the carbon intensity of its controlled fleet by 50% by 2030 compared to

Veoneer estimates full year 2020 total order book and new order intake

Stockholm, Sweden, January 7, 2021: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB) estimates its current total order book value for full year 2020 to be approximately $14 billion. During 2020, Veoneer divested its brake control business with an estimated order book value of around $4 billion, which is excluded from the current estimate. Reductions in the expectations for the global light vehicle production until 2025 further reduced the order book estimate by about $1 billion compared to the estimate from one year ago.Lifetime value of the new order intake for

RECOMMENDATION FROM THE NOMINATION COMMITTEE TO VOTE “NO” TO SAND GROVE’S PROPOSAL

We refer to Sand Grove Capital Management LLP’s (“Sand Grove”) proposal to replace the Chairman of the Nomination Committee before the expiration of his term at the extraordinary general meeting it has requested on 15 January 2021. The Committee does not support this proposal. The Nomination Committee is of the opinion that the company’s largest shareholder, Sand Grove, should as a principle be represented in the Nomination Committee. As a result, the current chairman of the Committee has several times, both before and after Sand Grove’s failed extraordinary general meeting in September,

Flexion Mobile signs Illusion Connect from Superprism Technology

LONDON, 7th of January, 2021 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today announced that it has signed an agreement with Superprism Technology for Illusion Connect. It is a newly launched and successful real-time strategy game. The game was launched in Google Play in October 2020 and according to Sensor Tower it generated more than USD 1 million net revenue in December 2020 in Google Play. Distribution rights have been secured for all Flexion key channels. Flexion currently has a live portfolio of 20 games and 4 games pending launch.

OncoZenge announces issue of European Patent related to BupiZenge[®]

OncoZenge AB (publ), Moberg Pharma’s subsidiary, today announced that the European Patent Office (EPO) has granted patent 3 284 459 which protects BupiZenge[®], currently in development for treatment of pain due to oral mucositis. The patent is expected to be in effect until 2032.The new patent protects sustained-release lozenge containing bupivacaine, for treatment or alleviation of pain in the oral cavity. It is a divisional of the previously granted European patent 2 701 681, that specifically protects the use of lozenges for treatment of pain due to oral mucositis for cancer patients.

OncoZenge announces issue of European Patent related to BupiZenge[®]

OncoZenge AB (publ), Moberg Pharma’s subsidiary, today announced that the European Patent Office (EPO) has granted patent 3 284 459 which protects BupiZenge[®], currently in development for treatment of pain due to oral mucositis. The patent is expected to be in effect until 2032.The new patent protects sustained-release lozenge containing bupivacaine, for treatment or alleviation of pain in the oral cavity. It is a divisional of the previously granted European patent 2 701 681, that specifically protects the use of lozenges for treatment of pain due to oral mucositis for cancer patients.

Qlife CE-marks COVID-19 test

Qlife announces that the company has CE-marked its PCR test for Sars-CoV-2 for professional use on the mobile test platform Egoo.Health and that the commercialization can begin immediately.The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market. The next step is to place the COVID-19 test in strategic locations, where it can offer fast and reliable results with help from healthcare professionals. “With this CE-marking, Qlife has achieved an important regulatory milestone. Our COVID-19-test is one of the first mobile PCR tests

LMC, Subsidiary of Alma Career, Acquires a Czech Start-up to Reinforce IT Recruitment Services

Alma Media Corporation                                         Press release                         7 January,  2021 LMC, SUBSIDIARY OF ALMA CAREER, ACQUIRES A CZECH START-UP TO REINFORCE IT RECRUITMENT SERVICES A leading recruitment service company in the Czech Republic LMC s.r.o, a member of the Alma Media Group and a subsidiary of Alma Career Oy, has acquired a Czech start-up Quantiq s.r.o. The company’s SaaS-based recruitment service Techloop.io is a niche portal designed for IT professionals and businesses. The parties have agreed not to disclose the price of the transaction.

Skanska builds Orlando Health Jewett Orthopedic Institute in Florida, USA, for about USD 64M, about SEK 524M

Skanska has signed a contract with Orlando Health, Inc. to construct the new Orlando Health Jewett Orthopedic Institute in Orlando, Florida, USA. The contract is worth about USD 64M, about SEK 524M, which will be included in the US order bookings for the fourth quarter 2020.The new 371,000-square-foot (about 35,000 sqm) institute will include an eight-story hospital that will house 75 inpatient rooms and 10 operating rooms (ORs). An adjoining 6-story medical office building will include two floors of ambulatory suites which will contain an added 12 ORs. The inpatient and outpatient facility

Peab builds apartments and retail space in Visby

Peab has been commissioned to build 60 apartments and two stores in southern Visby on Gotland. The customer is BRF Ordboken and the contract is worth SEK 106 million.BRF Ordboken is a new residential block that consists of three separate buildings where all the apartments have big balconies and terraces. The buildings will have plastered facades with staircase walls in cement. One of the buildings will have two stores on the ground floor. The residential environment will be modern and the block will have a courtyard with green oases and a pool for association members. “We are very happy

UNION therapeutics A/S receives FDA approval for IND of oral next generation PDE4-inhibitor (orismilast) for investigation in plaque psoriasis

· Orismilast is a next generation oral PDE4-inhibitor with an improved therapeutic window compared to other PDE4-inhibitors · Oral orismilast (UNI50001) has demonstrated proof of concept in patients living with plaque psoriasis and indicated “best-in-class” potential · PDE4-inhibition is a validated pharmacological target published for a broad range of inflammatory indications[1] · The improved therapeutic window of orismilast suggests potential for use in a number of inflammatory conditions, which have so far been limited by the typical narrow therapeutic window of PDE4-inhibitors

Finnair Traffic Performance in December 2020

Finnair Plc                Investor News        7 January 2021 at 9:00 a.m. EET The COVID-19 pandemic impact was clearly visible in the December passenger traffic figures, still strong month for cargo In December, Finnair carried 92,500 passengers, which was 92.0% less than in the corresponding period of 2019 but 8.8% more than in November 2020. The COVID-19 impact, including the exceptionally strict travel restrictions imposed by Finland, still affected all passenger traffic figures. It was visible especially in the North Atlantic figures (no scheduled flights in December). The

Catena Media appoints Göran Blomberg as interim CEO

Catena Media plc (Nasdaq Stockholm: CTM) The Board of Directors of Catena Media PLC announces that Göran Blomberg has been appointed interim CEO of Catena Media. Mr. Blomberg has been a member of the board of Catena Media since 2019 and chairman since 2020. He replaces Per Hellberg who leaves the company today. A search process for a new permanent CEO will now be undertaken.Mr. Blomberg will step down as chairman of the Board during his time as interim CEO. Öystein Engebretsen will serve as acting chairman during Mr. Blomberg’s tenure as CEO. “We are pleased to appoint Göran Blomberg

European Scale-up Action for Risk Capital (ESCALAR) kicks off: First ESCALAR project signed with Swedish equity fund manager eEquity

The first transaction under the joint European Commission and European Investment Fund (EIF) “European Scale-up Action for Risk capital” (ESCALAR) pilot programme, backed by the Investment Plan for Europe, has been signed. The first project concerns eEquity IV fund, which will support scale-ups and high-growth SMEs and small mid-caps in several EU Member States, with a focus on the Nordics.eEquity, a digital growth equity investor in the Nordics, announces the final close of eEquity IV, which will invest growth capital in disruptive European internet businesses. The fund benefits from a SEK

There are no items matching the current filter
There are no more items matching the current filter
Back to top